Chase AIPricingFAQs
Display currency
Loading news…

Erydel

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
San Giovanni, Molise, Italy Founded 2007 11-50 employees For Profit

Erydel develops technology for drug delivery of pharmacological agents through red blood cells.

Erydel was acquired by Quince Therapeutics in 2023.
Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
5
Patents
4

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
16
Active products
12
Patents granted
4
Trademarks
0
Top patent class
Medical Or Veterinary Science; Hygiene
IT spend
$9M

Company Info

Founded
2007
Employees
11-50
Operating status
Active
Company type
For Profit
Org types
company
Founders
1
News articles
12
HQ
San Giovanni, Molise, Italy
Region
European Union (EU), Europe, Middle East, and Africa (EMEA)
Exit date
Jul 24, 2023

Signals & Scores

Heat score
Low
Growth score
Low
Trend (7d)
0
Trend (30d)
1.5
Trend (90d)
-0.5

Key People at Erydel

Founder & CSO
Chief Executive Officer and Board Member
COO
5
professional contacts at Erydel
Contact execs at Erydel

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Erydel

Loading news…

FAQs about Erydel

People who checked this page also checked these

Browse the full Acquirezy directory.
Erydel - Company Profile, Full Acquisitions List, Funding and Investments